This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RABAVERT rabies vaccine with diluents. The award, valued at $47,426.00, is a Firm Fixed Price Delivery Order that will run through November 19, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,954.50 firm fixed-price delivery order is for the supply of RABAVERT Rabies Vaccine with diluents. The contract has an ultimate completion date of October 30, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,026.38 firm fixed-price delivery order is for the RABAVERT rabies vaccine with diluents, with a completion date of December 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a range of...
This federal contract award, valued at $1,352.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RABAVERT rabies vaccine with diluents. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 30, 2024. AmerisourceBergen, through its Corporate Office division, is an experienced government contractor that supplies a wide range of pharmaceutical...
This federal contract award, valued at $1,737.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a critical medical product, with a completion date of January 28, 2025. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,665.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical commodity used to prevent rabies infection. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $18,429.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with a completion date of March 24, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
This federal contract award is a delivery order valued at $2,613.14 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a period of performance through May 31, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $16,766.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT rabies vaccine with diluents, a critical medical commodity used in federal healthcare programs. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,191.60, is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a rabies vaccine product, with a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...